Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Year Study of Lipid Emulsions and Liver Function in Chronic Intestinal Failure
NCT04347902Phase 4Completed
- Sponsor
- Stanley Dudrick Memorial Hospital
- Start
- Jan 2016
- Primary completion
- Mar 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of SMOFlipid in intestinal failure-associated liver disease (IFALD), sponsored by Stanley Dudrick Memorial Hospital. Started Jan 2016; status: completed.
02
Drugs
SMOFlipid
03
Conditions
intestinal failure-associated liver disease (IFALD)
Beyond the preview
Go deeper on NCT04347902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347902.